Login
Navigate Fool.com
Will CNAT beat
the market?
Community Rating: 2 Stars: Unattractive

8.20 0.45 (5.81%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.85
Previous Close $7.75
Daily Range $7.71 - $8.29
52-Week Range $5.06 - $15.67
Market Cap $128.2M
P/E Ratio 6.46
Dividend (Yield) $0.00 (0.0%)
Volume 503,614
Average Daily Volume 1,155,065
Current FY EPS -$1.68

How do you think CNAT
will perform against the market?

Top CNAT Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted February 3, 2014

Here's a great idea for a business plan. Put together a biopharma company based on a hot preclinical platform. Sell out to big pharma for hundreds of millions before running a single clinical trial. T … More

0 Replies Reply Report this Post
 

sinvestor (< 20)
Submitted January 14, 2014

Really???

0 Replies Reply Report this Post

News & Commentary Rss Feed

3 Reasons Potential Side Effects Trump Positive Phase 3 Data

Cardiovascular side effects might kill Intercept's chances for off-label use, killing OCA's chances to get established well ahead of Conatus Pharmaceuticals, Gilead Sciences and Isis Pharmaceuticals.

Wednesday Sector Leaders: Precious Metals, Drugs

Why SodaStream, Intercept Pharmaceuticals, and lululemon athletica Tumbled Today

The falling stock market sent the Dow and S&P 500 to their worst levels of the year, and warnings from these and other stocks played a big role in the overall declines. SodaStream plunged 26%, while Intercept Pharmaceuticals gave back 18% and lululemon athletica fell 17%. Find out more about why these stocks plunged today.

516% Jump for Intercept Pharmaceuticals, Unknown Biotech With Unlikely Outcome

Intercept Pharmaceuticals jumps on phase 2 data for obeticholic acid in patients with NASH.

Pre-Market Most Active for Jan 10, 2014 : NOK, BAC, AA, QQQ, TGT, INFY, NVO, CNAT, MNKD, FB, XIV, M

Pre-Market Most Active for Jan 10, 2014 : NOK, BAC, AA, QQQ, TGT, INFY, NVO, CNAT, MNKD, FB, XIV, MSFT

Intercept Pharmaceuticals Inc: A Whole New Class of Blockbuster Drug Is Born

Why Intercept Pharmaceuticals just quadrupled and Conatus Pharmaceuticals saw a 70% gain.

Healthcare Stocks Adding to Earlier Gains; Big Rally by Intercept Pharma Also Raising Peers

Sector Update: Healthcare

See More CNAT News...

Sector

Industry

CONATUS PHARMACEUTICALS INC (CNAT) Description

CONATUS PHARMACEUTICALS INC Website: http://www.conatuspharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks